BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12650523)

  • 21. Use of the tetracycline system for inducible protein synthesis in the kidney.
    Gallagher AR; Schönig K; Brown N; Bujard H; Witzgall R
    J Am Soc Nephrol; 2003 Aug; 14(8):2042-51. PubMed ID: 12874458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of muscle creatine kinase promoter activity by the inducible orphan nuclear receptor TIS1.
    Yang WL; Lim RW
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):281-7. PubMed ID: 9020856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New doxycycline-inducible transgenic lines in Xenopus.
    Rankin SA; Zorn AM; Buchholz DR
    Dev Dyn; 2011 Jun; 240(6):1467-74. PubMed ID: 21491543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of the Tet-On system for inducible expression of RAGE.
    Shaikh S; Nicholson LF
    J Biomol Tech; 2006 Sep; 17(4):283-92. PubMed ID: 17028168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of doxycycline-controlled gene expression to reversibly alter milk-protein composition in transgenic mice.
    Soulier S; Stinnakre MG; Lepourry L; Mercier JC; Vilotte JL
    Eur J Biochem; 1999 Mar; 260(2):533-9. PubMed ID: 10095792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A doxycycline-inducible, tissue-specific aromatase-expressing transgenic mouse.
    Chow JD; Price JT; Bills MM; Simpson ER; Boon WC
    Transgenic Res; 2012 Apr; 21(2):415-28. PubMed ID: 21614586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xenobiotic response in humanized double transgenic mice expressing tetracycline-controlled transactivator and human CYP1B1.
    Hwang DY; Chae KR; Shin DH; Hwang JH; Lim CH; Kim YJ; Kim BJ; Goo JS; Shin YY; Jang IS; Cho JS; Kim YK
    Arch Biochem Biophys; 2001 Nov; 395(1):32-40. PubMed ID: 11673863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice.
    Zhu Z; Ma B; Homer RJ; Zheng T; Elias JA
    J Biol Chem; 2001 Jul; 276(27):25222-9. PubMed ID: 11331286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing tTA transgenic rats for inducible and reversible gene expression.
    Zhou H; Huang C; Yang M; Landel CP; Xia PY; Liu YJ; Xia XG
    Int J Biol Sci; 2009; 5(2):171-81. PubMed ID: 19214245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetracycline-inducible system for photoreceptor-specific gene expression.
    Chang MA; Horner JW; Conklin BR; DePinho RA; Bok D; Zack DJ
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4281-7. PubMed ID: 11095627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of tetracycline-inducible bitransgenic Krt12rtTA/+/tet-O-LacZ mice.
    Chikama T; Hayashi Y; Liu CY; Terai N; Terai K; Kao CW; Wang L; Hayashi M; Nishida T; Sanford P; Doestchman T; Kao WW
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1966-72. PubMed ID: 15914610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis.
    Bojak A; Hammer D; Wolf H; Wagner R
    Vaccine; 2002 May; 20(15):1975-9. PubMed ID: 11983257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tight regulation of transgene expression by tetracycline-dependent activator and repressor in brain.
    Uchida S; Sakai S; Furuichi T; Hosoda H; Toyota K; Ishii T; Kitamoto A; Sekine M; Koike K; Masushige S; Murphy G; Silva AJ; Kida S
    Genes Brain Behav; 2006 Feb; 5(1):96-106. PubMed ID: 16436193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate.
    Rao V; Heard JC; Ghaffari H; Wali A; Mutton LN; Bieberich CJ
    Prostate; 2012 Jul; 72(10):1045-51. PubMed ID: 22297979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector.
    Strathdee CA; McLeod MR; Hall JR
    Gene; 1999 Mar; 229(1-2):21-9. PubMed ID: 10095100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancer.
    Himeda CL; Ranish JA; Angello JC; Maire P; Aebersold R; Hauschka SD
    Mol Cell Biol; 2004 Mar; 24(5):2132-43. PubMed ID: 14966291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice.
    Shield MA; Haugen HS; Clegg CH; Hauschka SD
    Mol Cell Biol; 1996 Sep; 16(9):5058-68. PubMed ID: 8756664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of promoter region constructs for in vivo intramuscular expression.
    Fabre EE; Bigey P; Orsini C; Scherman D
    J Gene Med; 2006 May; 8(5):636-45. PubMed ID: 16477670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells.
    Freundlieb S; Schirra-Müller C; Bujard H
    J Gene Med; 1999; 1(1):4-12. PubMed ID: 10738580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted transgenesis at the HPRT locus: an efficient strategy to achieve tightly controlled in vivo conditional expression with the tet system.
    Palais G; Nguyen Dinh Cat A; Friedman H; Panek-Huet N; Millet A; Tronche F; Gellen B; Mercadier JJ; Peterson A; Jaisser F
    Physiol Genomics; 2009 Apr; 37(2):140-6. PubMed ID: 19141541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.